NCT00430547
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
- Locations
-
- Barwon Health - The Geelong Hospital Geelong, Victoria, Australia
Clinical trial condition
Exophthalmos
Explore clinical trials studying Exophthalmos. Study availability and eligibility vary by location and protocol.
225 public trials
64 recruiting studies
Exophthalmos trial results
NCT00150111
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
- Locations
-
- Department of Endocrinology, Odense University Hospital Odense, Funen, Denmark
- Department of Hematology, Odense University Hospital Odense, Denmark
NCT00312325
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +17 more
- Locations
-
- Department of Clinical Pharmacology Vienna, Austria
NCT00150137
- Conditions
- Autoimmune Diseases, Endocrine System Diseases, Exophthalmos, +8 more
- Locations
-
- Department of Endocrinology, Odense University Hospital Odense, Funen, Denmark
Active, Not Recruiting
A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease
NCT06248619
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
- Locations
-
- Catalina Eye Care - NVISION - PPDS Tucson, Arizona, United States
- Advanced Quality Medical Research Orland Park, Illinois, United States
- W Kellogg Eye Center Ann Arbor, Michigan, United States
- Las Vegas Endocrinology Henderson, Nevada, United States
Active, Not Recruiting
A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease
NCT06557850
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
- Locations
-
- University Clinical Center of The Republic Of Srpska Banja Luka, Republika Srpska, Bosnia and Herzegovina
- Diagnostic-Consultative Center Alexandrovska Sofia, Bulgaria
- University Specialized Hospital for Active Treatment in Endocrinology (USHATE) "Acad. Ivan Penchev" Sofia, Bulgaria
- Jagiellonian University Medical College Krakow, Lesser Poland Voivodeship, Poland
Active, Not Recruiting
A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
NCT06812325
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
- Locations
-
- Catalina Eye Care Tuscon, Arizona, United States
- United Medical Research Institute Inglewood, California, United States
- Orbital Plastics Newport Beach, California, United States
- California Eye Specialists Medical Group INC Pasadena, California, United States
Active, Not Recruiting
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)
NCT06625398
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
- Locations
-
- Scottsdale Clinical Trials Scottsdale, Arizona, United States
- Alliance Research Institute - Canoga Park Canoga Park, California, United States
- Marvel Clinical Research Huntington Beach, California, United States
- United Medical Research Institute Inglewood, California, United States
Active, Not Recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
NCT06106828
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
- Locations
-
- Plastics-Orbit-Neuro San Diego, California, United States
- Connecticut Eye Consultants, P.C. Danbury, Connecticut, United States
- University of Illinois Eye and Ear Infirmary Chicago, Illinois, United States
- Scheie Eye Institute Philadelphia, Pennsylvania, United States
Active, Not Recruiting
Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
NCT05987423
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
- Locations
-
- Thrive Health Research LLC Beverly Hills, California, United States
- UCSD Shiley Eye Center La Jolla, California, United States
- Grene Vision Group, LLC Wichita, Kansas, United States
- Johns Hopkins University Baltimore, Maryland, United States